Jump to main content
Jump to site search

Issue 1, 2011
Previous Article Next Article

Metabolic-targeted therapy with dichloroacetate (DCA): a novel treatment strategy to improve the outcome of photodynamic therapy

Author affiliations

Abstract

For the first time we present data showing that metabolic targeted therapy with dichloroacetate (DCA) may improve the outcome of photodynamic therapy. This treatment modality can be easily introduced into clinical practice guidelines.

Graphical abstract: Metabolic-targeted therapy with dichloroacetate (DCA): a novel treatment strategy to improve the outcome of photodynamic therapy

Back to tab navigation

Publication details

The article was received on 24 Jun 2010, accepted on 27 Sep 2010 and first published on 26 Oct 2010


Article type: Communication
DOI: 10.1039/C0PP00193G
Citation: Photochem. Photobiol. Sci., 2011,10, 25-28

  •   Request permissions

    Metabolic-targeted therapy with dichloroacetate (DCA): a novel treatment strategy to improve the outcome of photodynamic therapy

    M. Kwitniewski, J. Moan and A. Juzeniene, Photochem. Photobiol. Sci., 2011, 10, 25
    DOI: 10.1039/C0PP00193G

Search articles by author

Spotlight

Advertisements